Evas Therapeutics Overview
- Year Founded
-
2003
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Evas Therapeutics General Information
Description
Developer of novel therapies for debilitating diseases associated with tissue injury and cell death. The company develops therapy for pharmacotherapy of various debilitating diseases including acute myocardial infarction, stroke, unstable atherosclerotic diseases, transplant rejection, hemodialysis vascular access failure and neurodegenerative diseases, enabling physicians to cure diseases.
Contact Information
Corporate Office
- 613 Huntley Heights Drive
- Ballwin, MO 63021
- United States
Corporate Office
- 613 Huntley Heights Drive
- Ballwin, MO 63021
- United States
Evas Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Aug-2019 | Completed | Out of Business | |||
| 2. Grant | 01-Jan-2018 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Evas Therapeutics FAQs
-
When was Evas Therapeutics founded?
Evas Therapeutics was founded in 2003.
-
Where is Evas Therapeutics headquartered?
Evas Therapeutics is headquartered in Ballwin, MO.
-
What industry is Evas Therapeutics in?
Evas Therapeutics’s primary industry is Drug Discovery.
-
Is Evas Therapeutics a private or public company?
Evas Therapeutics is a Private company.
-
What is Evas Therapeutics’s current revenue?
The current revenue for Evas Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
